Animal Vaccines Market, by Product Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines), by Application (Companion Animal, Livestock Animal, Poultry, and Aquac

Animal Vaccines Market, by Product Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines), by Application (Companion Animal, Livestock Animal, Poultry, and Aquaculture), by Distribution Channel (Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Animal vaccines are parenteral products that are used as prophylactic as well as in the treatment of various veterinary diseases. Animal vaccines play a crucial role in ensuring good health, longevity, and improving overall productivity of pets and livestock, in a cost-effective manner. Companion animal vaccines reduce transmission of various diseases from animals to humans. These vaccines are parenteral products that are used in prophylactic treatment of various diseases such as blastomycosis, psittacosis cat scratch disease, and others.

Market Dynamics

Vaccines are preventive medicines for the treatment of various diseases. Some of the vaccines are expensive to afford. So various companies operating in the global animal vaccines market offer reimbursement to reduce the expenses of pet vaccinations which is expected to augment the market growth over the forecast period. For instance, For canine patients receiving an ULTRA Duramune DAP combination and Bronchi-Shield ORAL, Elanco reimburses normal and customary charges (up to US$ 5,000) associated with the diagnosis and treatment of any patient suffering respiratory disease due to canine parainfluenza virus infection Moreover, Elanco reimburses standard and reasonable diagnostics (a biopsy and histopathological exam) to reach a definitive diagnosis. With a confirmed diagnosis, Elanco reimburses standard and reasonable treatment costs up to US$ 1,500. For canine patients receiving an ULTRA Duramune DAP combination and Bronchi-Shield ORAL, Elanco reimburses normal and customary charges (up to US$ 5,000) associated with the diagnosis and treatment of any patient suffering respiratory disease due to canine parainfluenza virus infection.

Moreover, various pet health insurance companies provide coverage for vaccines, examinations, teeth cleaning, spaying, and other pet health related activities. Some of the pet health insurance companies include ASPCA Pet Insurance, PetFirst Insurance, Embrace Pet Insurance Agency, and PetPlan, Allstate Insurance Company, among others.

Key features of the study:

  • This report provides an in-depth analysis of the global animal vaccines market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global animal vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies.
  • Key companies covered as a part of this study include Merck & Co., Inc., Boehringer Ingelheim International GmbH., Zoetis Inc., Elanco Animal Health Incorporated, Ceva, HIPRA, Romvac Company Sa, Biovac, Vaxxinova International BV, and Biogénesis Bagó
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global animal vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global animal vaccines market
Detailed Segmentation:
  • Global Animal Vaccines Market, By Product Type :
  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • Global Animal Vaccines Market, By Application:
  • Companion Animal
  • Livestock Animal
  • Poultry
  • Aquaculture
  • Global Animal Vaccines Market, By Distribution Channel:
  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Others
  • Global Animal Vaccines Market, By Region:
  • North America
  • By Product Type
  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • By Application
  • Companion Animal
  • Livestock Animal
  • Poultry
  • Aquaculture
  • By Distribution Channel
  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Others
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Product Type
  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • By Application
  • Companion Animal
  • Livestock Animal
  • Poultry
  • Aquaculture
  • By Distribution Channel
  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Others
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Product Type
  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • By Application
  • Companion Animal
  • Livestock Animal
  • Poultry
  • Aquaculture
  • By Distribution Channel
  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Others
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product Type
  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • By Application
  • Companion Animal
  • Livestock Animal
  • Poultry
  • Aquaculture
  • By Distribution Channel
  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Others
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Product Type
  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • By Application
  • Companion Animal
  • Livestock Animal
  • Poultry
  • Aquaculture
  • By Distribution Channel
  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Others
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product Type
  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • By Application
  • Companion Animal
  • Livestock Animal
  • Poultry
  • Aquaculture
  • By Distribution Channel
  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Others
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Merck & Co., Inc.*
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Boehringer Ingelheim International GmbH.
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Ceva
  • HIPRA
  • Romvac Company Sa
  • Biovac
  • Vaxxinova International BV
  • Biogénesis Bagó
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Application
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Drivers and Restraints
Opportunities
Impact Analysis
Key developments
New Product Launches
Partnerships and Agreements
Technological Landscape
Brand Analysis
Regulatory Scenario
Epidemiology
Reimbursement Schemes
PORTER Analysis
4. Global Animal Vaccines Market– Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply and Demand Analysis
Key Developments
5. Global Animal Vaccines Market, By Product Type, 2017 – 2028, (US$ Mn)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2017 – 2028
Segment Trends
Attenuated Live Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Conjugate Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Inactivated Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Subunit Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Toxoid Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
DNA Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Recombinant Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
6. Global Animal Vaccines Market, By Application, 2017 – 2028, (US$ Mn)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2017 – 2028
Segment Trends
Companion Animal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Livestock Animal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Poultry
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Aquaculture
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
7. Global Animal Vaccines Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2017 – 2028
Segment Trends
Veterinary Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
Veterinary Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
Veterinary Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
8. Global Animal Vaccines Market, By Region, 2017 – 2028, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2021 and 2028 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2028
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country 2017 – 2028, (US$ Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2028, (US$ Mn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Company Profiles
Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Boehringer Ingelheim International GmbH
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Zoetis Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Elanco Animal Health Incorporated
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Ceva
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
HIPRA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Romvac Company Sa
Company Highlights
Product Portfolio
Key Highlights
Strategies
Biovac
Company Highlights
Product Portfolio
Key Highlights
Strategies
Vaxxinova International BV
Company Highlights
Product Portfolio
Key Highlights
Strategies
Biogénesis Bagó
Company Highlights
Product Portfolio
Key Highlights
Strategies
10. Section
Research Methodology
About Us
*Browse 28 market data tables and 78 figures on "Animal Vaccines Market” - Global forecast to 2028

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings